Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda
…, E Ivan, JM Semahore, JB Mazarati, CS Merle… - The Lancet …, 2020 - thelancet.com
Background The Xpert MTB/RIF (Xpert) assay is used globally to rapidly diagnose tuberculosis
and resistance to rifampicin. We investigated the frequency and predictors of false-…
and resistance to rifampicin. We investigated the frequency and predictors of false-…
Enabling countries to manage outbreaks: statistical, operational, and contextual analysis of the early warning and response system (EWARS-csd) for dengue …
…, ME Borbón Ramos, MO Sewe, CS Merle… - Frontiers in Public …, 2024 - frontiersin.org
Introduction Dengue is currently the fastest-spreading mosquito-borne viral illness in the
world, with over half of the world's population living in areas at risk of dengue. As dengue …
world, with over half of the world's population living in areas at risk of dengue. As dengue …
[HTML][HTML] Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam
TMP Nguyen, THM Le, CSC Merle, D Pedrazzoli… - International Journal of …, 2023 - Elsevier
Objectives World Health Organization recommends a 7-drug 9–11-month rifampicin-resistant
tuberculosis (RR-TB) short treatment regimen (STR). To reduce the pill burden, we …
tuberculosis (RR-TB) short treatment regimen (STR). To reduce the pill burden, we …
Health-related quality of life of tuberculosis patients during the COVID-19 pandemic in Conakry, Guinea: a mixed methods study
…, A Delamou, V Veronese, CS Merle… - Tropical Medicine and …, 2022 - mdpi.com
The COVID-19 pandemic has had a significant impact on all facets of life and has exacerbated
many challenges faced by people living with tuberculosis (TB). This study aimed to …
many challenges faced by people living with tuberculosis (TB). This study aimed to …
Prevalence of asymptomatic malaria parasitaemia following mass testing and treatment in Pakro sub-district of Ghana
Background Global efforts to scale-up malaria control interventions are gaining steam. These
include the use of Long-Lasting Insecticide Nets, Indoor Residual Spraying, Intermittent …
include the use of Long-Lasting Insecticide Nets, Indoor Residual Spraying, Intermittent …
Challenges and perceptions of implementing mass testing, treatment and tracking in malaria control: a qualitative study in Pakro sub-district of Ghana
…, D Okyere, JY Enos, A Amambua-Ngwa, CSC Merle… - BMC Public Health, 2019 - Springer
Background Malaria remains endemic in Ghana despite several interventions. Studies have
demonstrated very high levels of asymptomatic malaria parasitaemia in both under-five and …
demonstrated very high levels of asymptomatic malaria parasitaemia in both under-five and …
Delays in TB diagnosis and treatment initiation in Burkina Faso during the COVID-19 pandemic
…, S Ouédraogo, IT Traoré, CS Merle - Tropical Medicine and …, 2022 - mdpi.com
The COVID-19 pandemic has significantly disrupted TB services, particularly in low resource
settings. In Burkina Faso, a cross-sectional ‘before and after’ study was conducted to …
settings. In Burkina Faso, a cross-sectional ‘before and after’ study was conducted to …
How to improve access to TB care for the nomads? Review of barriers and enablers for Sahel nomadic populations
…, B Konaté, Y Ballayira, F Camara, M Roij, CS Merle - medRxiv, 2022 - medrxiv.org
Tuberculosis (TB) control in nomadic populations represents a major public health problem
in sub–Saharan Africa. Barriers and enablers of TB care for nomads were identified through …
in sub–Saharan Africa. Barriers and enablers of TB care for nomads were identified through …
Evaluating the effectiveness of a novel systematic screening approach for tuberculosis among individuals suspected or recovered from COVID-19: Experiences from …
…, JR Campbell, V Veronese, CSC Merle - Tropical Medicine and …, 2022 - mdpi.com
Evidence suggests that the COVID-19 pandemic negatively impacts tuberculosis (TB)
activities. As TB and COVID-19 have similar symptoms, we assessed the effectiveness of …
activities. As TB and COVID-19 have similar symptoms, we assessed the effectiveness of …
Hepatic Safety of High-Dose Rifampicin for Tuberculosis Treatment in TB/HIV Co-infected Patients: A Randomized Clinical Tria
S Sanni, AP Wachinou, CSC Merle… - Archives of Pharmacy …, 2021 - archivepp.com
High-dose Rifampicin regimens have been shown to be more effective for tuberculosis (TB)
treatment in TB/HIV co-infected patients. This study assessed the hepatic safety of a high-…
treatment in TB/HIV co-infected patients. This study assessed the hepatic safety of a high-…
